Santhera Pharmaceuticals Holding AG: Shareholders Approve all Board Proposals at Today s Annual General Meeting finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
Shareholders Approve all Board Proposals at Today s Annual General Meeting tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.
Santhera Pharmaceuticals (OTCMKTS:SPHDF – Get Rating) is one of 412 publicly-traded companies in the “Biotechnology” industry, but how does it compare to its rivals? We will compare Santhera Pharmaceuticals to similar companies based on the strength of its dividends, institutional ownership, risk, earnings, analyst recommendations, profitability and valuation. Institutional and Insider Ownership 8.2% of Santhera […]
Vamorolone is Currently Under Review with the FDA (PDUFA Date of October 26, 2023) for the Treatment of Duchenne Muscular Dystrophy, a Rare Neuromuscular Disease
Vamorolone is Currently Under Review with the FDA for the Treatment of Duchenne Muscular Dystrophy, a Rare Neuromuscular Disease FDA has Granted Fast Track and Orphan Drug Designation for Vamorolone. | June 20, 2023